Articles tagged ‘’

Atrial fibrillation (AF) is more common in patients diagnosed with coeliac disease (CD), though the excess risk is small, according to a study¹ in a large cohort of patients with biopsy-verified CD published recently in the European Heart Journal.

Dr Henning Rud Andersen, Consultant Cardiologist (Aarhus University Hospital, Denmark) recently marked a significant personal milestone when his father was successfully treated for aortic stenosis using the procedure he pioneered.

A new 80-lead 3D echocardiogram (ECG) (Heartscape™, Verathon) system, which debuted at the European Society of Cardiology congress in Paris, aims to improve early diagnosis and help detect acute myocardial infarction (MI) missed by traditional systems.

High-dose allopurinol could reduce future cardiovascular mortality in coronary artery disease (CAD), “over and above existing optimum therapy”, according to a study published recently in the Journal of the American College of Cardiology.¹

Hospital referrals and associated costs could be reduced, and patient care enhanced, through the use of an online e-Consult service, according to commercial company Medical Efficiencies Online (MEO).

Processes that control heart rate play an important role in the quality of life experienced by patients with chronic obstructive pulmonary disease (COPD), according to a study¹ published recently in Respirology.

UK clinicians report on a case of lingual haematoma following thrombolysis, the results of which lead them to recommend that the dental status of patients presenting with acute coronary syndrome be reviewed prior to thrombolytic and anti-platelet treatments…

Despite significant improvements in stroke prevention over the past decade, and a fall in incidence and deaths, UK doctors are still undertreating atrial fibrillation (AF), according to research¹ published recently in BMJ Open.



Aspirin increases the risk of bleeding without decreasing the risk of stroke/thromboembolism sufficiently in patients with atrial fibrillation (AF), according to a study¹ published recently in Thrombosis and Haemostasis.

The European Society of Cardiology (ESC) has announced an educational programme at the 22nd Great Wall International Congress of Cardiology, held in Beijing from the 15–16th October, to help reduce the mortality rate due to cardiovascular disease (CVD) in China, now amongst the highest in the world.¹